TOP1 and lung adenocarcinoma: Moreover, the administration of AOAA or silencing of CBS suppressed the endogenous production of H2S, further leading to a drop in the viability of camptothecin (DNA topoisomerase I inhibitor)-treated lung adenocarcinoma cells, thereby eventually increasing the sensitivity of lung adenocarcinoma cells to chemotherapeutic drugs [143].